New 172-page Whistleblower Complaint to SEBl Documents Sun Pharma’s Nexus with Aditya Medisales – I
The Securities and Exchange Board of India (SEBI) has received a new complaint, a few weeks ago, against Sun Pharma. This too has been filed by the same whistleblower who had filed a complaint in September last year, which was first reported by Moneylife.
Premium Content
You can buy this article individually, which will give you access only to this article.
Pay Per Article Gift An Article
Already a subscriber ? Log in
Free Helpline
Legal Credit